Clusterin expression is upregulated following acute head injury and localizes to astrocytes in old head injury

There is mounting evidence linking traumatic brain injury (TBI) to neurodegeneration. Clusterin (apolipoprotein J or ApoJ) is a complement inhibitor that appears to have a neuroprotective effect in response to tissue damage and has been reported to be upregulated in Alzheimer's disease. Here we investigated the time course and cellular expression pattern of clusterin in human TBI. Tissue from 32 patients with TBI of varying survival times (from under 30 min to 10 months) was examined using immunohistochemistry for clusterin alongside other markers of neurodegeneration and neuroinflammation. TBI cases were compared to ischemic brain damage, Alzheimer's disease and controls. Double immunofluorescence was carried out in order to examine cellular expression. Clusterin was initially expressed in an axonal location less than 30 min following TBI and increased in intensity and the frequency of deposits with increasing survival time up to 24 h, after which it appeared to reduce in intensity but was still evident several weeks after injury. Clusterin was first evident in astrocytes after 45 min, being increasingly seen up to 48 h but remaining intense in TBI cases with long survival times. Our results suggest clusterin plays a role in modulating the inflammatory response of acute and chronic TBI and that it is a useful marker for TBI, particularly in cases with short survival times. Its prominent accumulation in astrocytes, alongside a mounting inflammatory response and activation of microglial cells supports a potential role in the neurodegenerative changes that occur as a result of TBI.

[1]  M. Viitanen,et al.  Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases , 2015, Neuropathology and applied neurobiology.

[2]  Ann C McKee,et al.  The Neuropathology of Chronic Traumatic Encephalopathy , 2015, Brain pathology.

[3]  M. Blankenstein,et al.  Apolipoproteins E and J interfere with amyloid‐beta uptake by primary human astrocytes and microglia in vitro , 2014, Glia.

[4]  D. Geschwind,et al.  Novel Roles for Osteopontin and Clusterin in Peripheral Motor and Sensory Axon Regeneration , 2014, The Journal of Neuroscience.

[5]  L. S. Murray,et al.  The neuroinflammatory response in humans after traumatic brain injury , 2013, Neuropathology and applied neurobiology.

[6]  Thomas W. Mühleisen,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.

[7]  Victoria E. Johnson,et al.  Chronic neuropathologies of single and repetitive TBI: substrates of dementia? , 2013, Nature Reviews Neurology.

[8]  G. Breen,et al.  Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway , 2012, Molecular Psychiatry.

[9]  N. Jahanshad,et al.  Common Alzheimer's Disease Risk Variant Within the CLU Gene Affects White Matter Microstructure in Young Adults , 2011, The Journal of Neuroscience.

[10]  Albert Hofman,et al.  Plasma clusterin and the risk of Alzheimer disease. , 2011, JAMA.

[11]  C. Troakes,et al.  Abnormal TDP‐43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease , 2010, Neuropathology : official journal of the Japanese Society of Neuropathology.

[12]  Susan M Resnick,et al.  Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. , 2010, Archives of general psychiatry.

[13]  T. Hortobágyi,et al.  TDP‐43 is consistently co‐localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

[14]  T. Suuronen,et al.  Clusterin: A forgotten player in Alzheimer's disease , 2009, Brain Research Reviews.

[15]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[16]  A. McKee,et al.  Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head Injury , 2009, Journal of neuropathology and experimental neurology.

[17]  F. Rizzi,et al.  Clusterin is a short half‐life, poly‐ubiquitinated protein, which controls the fate of prostate cancer cells , 2009, Journal of cellular physiology.

[18]  D. Michel,et al.  Stress‐Induced Retrotranslocation of Clusterin/ApoJ into the Cytosol , 2007, Traffic.

[19]  T. Hortobágyi,et al.  Traumatic axonal damage in the brain can be detected using β‐APP immunohistochemistry within 35 min after head injury to human adults , 2007, Neuropathology and applied neurobiology.

[20]  T. Suuronen,et al.  Amyloid-β 1–42 induced endocytosis and clusterin/apoJ protein accumulation in cultured human astrocytes , 2007, Neurochemistry International.

[21]  L. French,et al.  Sustained astrocytic clusterin expression improves remodeling after brain ischemia , 2006, Neurobiology of Disease.

[22]  Douglas H. Smith,et al.  Traumatic brain injury induces biphasic upregulation of ApoE and ApoJ protein in rats , 2005, Journal of neuroscience research.

[23]  H. Bramlett,et al.  Pathophysiology of Cerebral Ischemia and Brain Trauma: Similarities and Differences , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  G. Murray,et al.  Long term neuropsychological outcome after head injury: relation to APOE genotype , 2003, Journal of neurology, neurosurgery, and psychiatry.

[25]  A. Gundlach,et al.  Delayed, but prolonged increases in astrocytic clusterin (ApoJ) mRNA expression following acute cortical spreading depression in the rat: evidence for a role of clusterin in ischemic tolerance. , 2003, Brain research. Molecular brain research.

[26]  P. Mattsson,et al.  Complement activation in the human brain after traumatic head injury. , 2001, Journal of neurotrauma.

[27]  S. Al-Sarraj,et al.  Specificity and sensitivity of betaAPP in head injury. , 2001, Clinical neuropathology.

[28]  R. Witzgall,et al.  Regulation of clusterin expression following spinal cord injury , 2001, Cell and Tissue Research.

[29]  D. Holtzman,et al.  Clusterin contributes to caspase-3–independent brain injury following neonatal hypoxia-ischemia , 2001, Nature Medicine.

[30]  A Rostagno,et al.  Apolipoprotein J (clusterin) and Alzheimer's disease , 2000, Microscopy research and technique.

[31]  C. DeCarli,et al.  Head injury and the risk of AD in the MIRAGE study , 2000, Neurology.

[32]  H. Aldskogius,et al.  Glial cell responses, complement and apolipoprotein J expression following axon injury in the neonatal rat , 1999, Journal of neurocytology.

[33]  F. Rauzi,et al.  Neuronal loss up-regulates clusterin mRNA in living neurons and glial cells in the rat brain. , 1999, Neuroreport.

[34]  P. Giannakopoulos,et al.  Possible neuroprotective role of clusterin in Alzheimer’s disease: a quantitative immunocytochemical study , 1998, Acta Neuropathologica.

[35]  E. Törnqvist.  Complement and Clusterin in the Injured Nervous System , 1996 .

[36]  M. Svensson,et al.  Complement and clusterin in the injured nervous system , 1996, Neurobiology of Aging.

[37]  M E Rosenberg,et al.  Clusterin: physiologic and pathophysiologic considerations. , 1995, The international journal of biochemistry & cell biology.

[38]  C. Cheng,et al.  Regulation of Clusterin Secretion and mRNA Expression in Astrocytes by Cytokines , 1994, Molecular and Cellular Neuroscience.

[39]  L. Murray,et al.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[40]  C. Finch,et al.  Clusterin (SGP‐2): A multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain , 1994, The Journal of comparative neurology.

[41]  Yaakov Stern,et al.  Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community‐dwelling elderly persons and their first‐degree relatives , 1993, Annals of neurology.

[42]  Steven A. Johnson,et al.  Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat , 1990, Neuron.

[43]  U. Hengst,et al.  Targeting Axonal Protein Synthesis in Neuroregeneration and Degeneration , 2014, Neurotherapeutics.

[44]  N. Chauhan.  Chronic neurodegenerative consequences of traumatic brain injury. , 2014, Restorative neurology and neuroscience.

[45]  Nick C Fox,et al.  Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .

[46]  Agueda Rostagno,et al.  Clusterin and Alzheimer's disease. , 2005, Sub-cellular biochemistry.

[47]  健介 佐々木.  Increased clusterin(apolipoprotein J)expression in human and mouse brains infected with transmissible spongiform encephalopathies , 2002 .

[48]  C. Molgaard,et al.  Epidemiology of head trauma and neurocognitive impairment in a multi-ethnic population. , 1990, Neuroepidemiology.